GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.
From
To
GoodRx reports transitioning from injectable to oral GLP-1s can simplify weight loss routines, but requires careful timing and consistency.
LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration strategies for users.
Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those without obesity.
SaveHealth reports that GLP-1 medications aid in Type 2 diabetes and weight loss, but come with high costs.